These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 1327920)

  • 21. ATP and the binding of [3H]inositol 1,4,5-trisphosphate to its receptor.
    Willcocks AL; Nahorski SR
    Biochem J; 1988 Nov; 255(3):1061. PubMed ID: 2850794
    [No Abstract]   [Full Text] [Related]  

  • 22. Ca2(+)-mobilising properties of synthetic fluoro-analogues of myo-inositol 1,4,5-trisphosphate and their interaction with myo-inositol 1,4,5-trisphosphate 3-kinase and 5-phosphatase.
    Safrany ST; Sawyer D; Wojcikiewicz RJ; Nahorski SR; Potter BV
    FEBS Lett; 1990 Dec; 276(1-2):91-4. PubMed ID: 2176165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneity of [3H]inositol 1,4,5-trisphosphate binding sites in adrenal-cortical membranes. Characterization and validation of a radioreceptor assay.
    Challiss RA; Chilvers ER; Willcocks AL; Nahorski SR
    Biochem J; 1990 Jan; 265(2):421-7. PubMed ID: 2154189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ins(1,4,5)P3 metabolism and the family of IP3-3Kinases.
    Pattni K; Banting G
    Cell Signal; 2004 Jun; 16(6):643-54. PubMed ID: 15093605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inositol 1:2-cyclic,4,5-trisphosphate is only a weak agonist at inositol 1,4,5-trisphosphate receptors.
    Willcocks AL; Strupish J; Irvine RF; Nahorski SR
    Biochem J; 1989 Jan; 257(1):297-300. PubMed ID: 2537626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of 1L-chiro-inositol 2,3,5-trisphosphorothioate, the first partial agonist at the platelet myo-inositol 1,4,5-trisphosphate receptor.
    Liu C; al-Hafidh J; Westwick J; Potter BV
    Bioorg Med Chem; 1994 Apr; 2(4):253-7. PubMed ID: 7922136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. D-myo-inositol 1,4,5-trisphosphate analogues substituted at the 3-hydroxyl group.
    Hirata M; Watanabe Y; Kanematsu T; Ozaki S; Koga T
    Biochim Biophys Acta; 1995 Jun; 1244(2-3):404-10. PubMed ID: 7599161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inositol trisphosphate receptor localization in brain: variable stoichiometry with protein kinase C.
    Worley PF; Baraban JM; Colvin JS; Snyder SH
    Nature; 1987 Jan 8-14; 325(7000):159-61. PubMed ID: 3027583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis, calcium mobilizing, and physicochemical properties of D-chiro-inositol 1,3,4,6-tetrakisphosphate, a novel and potent ligand at the D-myo-inositol 1,4,5-trisphosphate receptor.
    Liu C; Davis RJ; Nahorski SR; Ballereau S; Spiess B; Potter BV
    J Med Chem; 1999 Jun; 42(11):1991-8. PubMed ID: 10354407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Formation and actions of calcium-mobilizing messenger, inositol 1,4,5-trisphosphate.
    Putney JW
    Am J Physiol; 1987 Feb; 252(2 Pt 1):G149-57. PubMed ID: 3030126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myo-inositol(1,4,5)trisphosphorothioate binds to specific [3H]inositol(1,4,5)trisphosphate sites in rat cerebellum and is resistant to 5-phosphatase.
    Willcocks AL; Potter BV; Cooke AM; Nahorski SR
    Eur J Pharmacol; 1988 Oct; 155(1-2):181-3. PubMed ID: 2854071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modification at C2 of myo-inositol 1,4,5-trisphosphate produces inositol trisphosphates and tetrakisphosphates with potent biological activities.
    Wilcox RA; Safrany ST; Lampe D; Mills SJ; Nahorski SR; Potter BV
    Eur J Biochem; 1994 Jul; 223(1):115-24. PubMed ID: 8033885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A role for nuclear inositol 1,4,5-trisphosphate kinase in transcriptional control.
    Odom AR; Stahlberg A; Wente SR; York JD
    Science; 2000 Mar; 287(5460):2026-9. PubMed ID: 10720331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two sulphonated dye compounds which compete for inositol 1,4, 5-trisphosphate binding to rat liver microsomes: effects on 5'-phosphatase activity.
    Bootman MD; Pay GF; Rick CE; Tones MA
    Biochem Biophys Res Commun; 1990 Feb; 166(3):1334-9. PubMed ID: 2154978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The preparation of intermediates for the synthesis of 1D-myo-inositol 1,4,5- and 2,4,5-trisphosphates, 1,4-bisphosphate 5-phosphorothioate, and 4,5-bisphosphate 1-phosphorothioate from 1D-3,6-di-O-benzyl-1,2-O-isopropylidene-myo-inositol.
    Desai T; Gigg J; Gigg R; Martín-Zamora E
    Carbohydr Res; 1994 Sep; 262(1):59-77. PubMed ID: 7954520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and evaluation of 1-position-modified inositol 1,4,5-trisphosphate analogs.
    Inoue T; Kikuchi K; Hirose K; Iino M; Nagano T
    Bioorg Med Chem Lett; 1999 Jun; 9(12):1697-702. PubMed ID: 10397504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design of potent and selective inhibitors of myo-inositol 1,4,5-trisphosphate 5-phosphatase.
    Safrany ST; Mills SJ; Liu C; Lampe D; Noble NJ; Nahorski SR; Potter BV
    Biochemistry; 1994 Sep; 33(35):10763-9. PubMed ID: 8075077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inositol phosphates: Does IP(4) run a protection racket?
    Irvine R
    Curr Biol; 2001 Mar; 11(5):R172-4. PubMed ID: 11267885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How do inositol phosphates regulate calcium signaling?
    Putney JW; Takemura H; Hughes AR; Horstman DA; Thastrup O
    FASEB J; 1989 Jun; 3(8):1899-905. PubMed ID: 2542110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and application of photoaffinity analogues of inositol 1,4,5-trisphosphate selectively substituted at the 1-phosphate group.
    Schäfer R; Nehls-Sahabandu M; Grabowsky B; Dehlinger-Kremer M; Schulz I; Mayr GW
    Biochem J; 1990 Dec; 272(3):817-25. PubMed ID: 2176480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.